Max Robotics — Global Service Robot Directory + US Certification

About

Yuya Iwahashi’s research focuses on the surgical and multimodal management of prostate cancer, with a particular emphasis on optimizing oncological outcomes and preserving health-related quality of life (HRQOL). His major contributions include comparative effectiveness studies of robot-assisted radical prostatectomy (RARP) versus high-dose-rate brachytherapy combined with external beam radiation and hormone therapy for high-risk prostate cancer, demonstrating that RARP may offer superior HRQOL in certain domains. He has also investigated the interplay between postoperative sexual function and overall HRQOL after RARP, revealing that preserved sexual function is associated with better urinary function outcomes. Iwahashi’s work has been cited over a dozen times, with his most-cited paper—a case report on undifferentiated pleomorphic sarcoma of the prostate in a young man—highlighting his diagnostic acumen in rare, aggressive urologic malignancies. His research is particularly notable for its patient-centered approach, integrating functional outcomes with traditional oncologic endpoints. Iwahashi’s findings contribute valuable evidence to guide treatment decisions for men with high-risk prostate cancer, balancing cancer control with long-term quality of life.